Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: PG97J3111A

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-12 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psoriasis 3 D011565 ClinicalTrials
Psoriasis 3 D011565 ClinicalTrials
Colitis, Ulcerative 1 D003093 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650437
FDA SRS PG97J3111A